1. Zuberbier T, Bernstein JA, Maurer M. Chronic spontaneous urticaria guidelines: What is new? J Allergy Clin Immunol 2022; 150: 1249-55.
2.
Bracken SJ, Abraham S, MacLeod AS. Autoimmune theories of chronic spontaneous urticaria. Front Immunol 2019; 10: 627.
3.
Akelma AZ, Mete E, Cizmeci MN, et al. The role of mean platelet volume as an inflammatory marker in children with chronic spontaneous urticaria. Allergol Immunopathol 2015; 43: 10-3.
4.
Metin Z, Akca HM, Tur K, Akogul S. Intersecting pathways: evaluating inflammatory markers and metabolism in chronic spontaneous urticaria with a multi-marker approach. Int J Dermatol 2024; 63: 604-10.
5.
Fok JS, Kolkhir P, Church MK, et al. Predictors of treatment response in chronic spontaneous urticaria. Allergy 2021; 76: 2965-81.
6.
Asero R, Tedeschi A, Riboldi P, et al. Severe chronic urticariais associated with elevated plasma levels of D-dimer. Allergy 2008; 63: 176-80.
7.
Asero R, Cugno M. Biomarkers of chronic spontaneous urticaria and their clinical implications. Expert Rev Clin Immunol 2021; 17: 247-54.
8.
Kasperska-Zajac A, Sztylc J, Machura E, et al.. Plasma IL6 concentration correlates with clinical disease activity and serum C reactive protein concentration in chronic urticaria patients. Clin Exp Allergy 2011; 41: 1386-91.
9.
Wolf J, Rose-John S, Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine 2014; 70: 11-20.
10.
Daye M, Temiz SA, Öztürk ENY, et al. Assessment of ELR, NLR, MPV, and CRP levels in patients with acne vulgaris. Cyprus J Med Sci 2022; 7: 241-4.
11.
Bilik MZ, Akıl MA, Acet H, et al. Usefulness of eosinophil-lymphocyte ratio in predicting stent restenosis. Dicle Med J 2016; 43: 299-304.
12.
Cai H, Huang H, Yang C, et al. Eosinophil-to-neutrophil ratio predicts poor prognosis of acute ischemic stroke patients treated with intravenous thrombolysis. Front Neurol 2021; 12: 665827.
13.
Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensiv. Care Med 1995; 21: S258-63.
14.
Przybilla B, Ring J, Völk M. Total IgE levels in the serum in dermatologic diseases. Hautarzt 1986; 37: 77-82.
15.
Saini SS, Klion AD, Holland SM, et al. The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils. J Allergy Clin Immunol 2000; 106: 514-20.
16.
Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1: unmet clinical needs in chronic urticaria. Allergy 2011; 66: 317-30.
17.
Stepaniuk P, Kan M, Kanani A. Natural history, prognostic factors and patient perceived response to treatment in chronic spontaneous urticaria. Allergy Asthma Clin Immunol 2020; 16: 63.
18.
Maurer M, Staubach P, Raap U, et al. H1-antihistamine-refractory chronic spontaneous urticaria: it’s worse than we thought – first results of the multicenter real-life AWARE study. Clin Exp Allergy 2017; 47: 684-92.
19.
Kolkhir P, Altrichter S, Hawro T, et al. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria. Allergy 2018; 73: 940-8.
20.
Aktas Karabay E, Aksu Cerman A, Kivanc AI. Serum C-reactive protein, neutrophil-lymphocyte ratio and uric acid levels in chronic spontaneous urticaria. Turk Klin J Dermatol 2016; 26: 125-31.
21.
Jørgensen KA, Stoffersen E. Heparin like activity of albumin. Thromb Res 1979; 16: 569-74.
22.
Liu L, Murray DK, Dameron CT, et al. Biochemical characterization of procoagulant albumin. Thromb Res 1997; 85: 399-411.
23.
Grzanka A, Damasiewicz-Bodzek A, Machura E, et al. Chronic spontaneous urticaria is characterized by lower serum advanced glycation end products. Biomed Res Int 2014; 2014: 974154.
24.
Plavsic A, Tomic-Spiric V, Arandjelovic S, et al. Biomarkers of disease activity in patients with chronic spontaneous urticaria. Adv Dermatol Alergol 2021; 38: 1017-22.
25.
PALA e, Bayraktar M. Relationship between C-reactive protein/albumin ratio and mucocutaneous symptom frequency and disease severity in Behçet’s disease. Turk J Med Sci 2024; 54: 4.
26.
Kalaycı BN, Balta İ. Evaluation of the serum C-reactive protein-albumin ratio and ist relationship with disease severity in alopecia areata: a prospective case-control study. J Cosmet Dermatol 2022; 21: 7194-9.
27.
Grattan CEH, Saini SS. Urticaria and Angioedema. In: Bolognia JL, Schaffer JV, Cerroni L, et al. Dermatology. 4th ed. Elsevier, China 2018; 304-19.
28.
Branicka O, Gawlik R, Glück J. Eosinophil to lymphocyte ratio may predict OCS reduction and change in quality of life (AQLQ) resulting from asthma biological treatment. Immunopharmacol Immunotoxicol 2024; 46: 212-7.
29.
Balta S, Celik T, Mikhailidis DP, et al. The relation between atherosclerosis and the neutrophil lymphocyte ratio. Clin Appl Thromb Hemost 2016; 22: 405-11.
30.
Sen BB, Rifaioglu EN, Ekiz O, et al. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol 2014; 33: 223-7.
31.
Göncü EK, Aktan Ş, Atakan N, et al. The Turkish guideline for the diagnosis and management of urticaria-2016. Turkderm 2016; 50.
32.
Cosansu NC. Effectiveness of the new inflammatory parameters in patients with chronic spontaneous urticaria. Cutan Ocul Toxicol 2020; 39: 71.
33.
Straesser MD, Oliver E, Palacios T, et al. Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria. J Allergy Clin Immunol Pract 2018; 6: 1386-8.
34.
Marzano AV, Genovese G, Casazza G, et al. Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients. J Eur Acad Dermatol Venereol 2019; 33: 918-24.
35.
Ertas R, Ozyurt K, Atasoy M, et al. The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change. Allergy 2018; 73: 705-12.
36.
Weller K, Ohanyan T, Hawro T, et al. Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab. Allergy 2018; 73: 2406-8.
37.
Koga T, Kawakami A. Interleukin-6 inhibition in the treatment of autoinflammatory diseases. Front Immunol 2022; 13: 956795.
38.
Xiao X, Hu X, Yao J, et al. The role of short-chain fatty acids in inflammatory skin diseases. Front Microbiol 2023; 13: 1083432.
39.
Fitzgerald D, Laurent M, Funaro M, et al. Defining the role of T lymphocytes in the immunopathogenesis of neuromyelitis optica spectrum disorder. Discov Med 2020; 29: 91-102.
40.
Zeng W, Xia J, Zeng Q. Levels of serum inflammatory cytokines and their correlations with disease severity in patients with chronic spontaneous urticaria. Adv Dermatol Allergol 2024; 41: 85-90.
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
